HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Joost J Oudejans Selected Research
Joost J Oudejans Research Topics
Disease
13
Neoplasms (Cancer)
01/2014 - 01/2002
8
B-Cell Lymphoma (Lymphoma, B Cell)
01/2008 - 03/2002
7
Lymphoma (Lymphomas)
04/2010 - 01/2002
6
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2010 - 03/2002
5
Male Breast Neoplasms (Male Breast Cancer)
12/2012 - 03/2012
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2006 - 01/2005
2
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2015 - 06/2002
2
Breast Neoplasms (Breast Cancer)
01/2014 - 08/2012
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2010 - 01/2002
2
Melanoma (Melanoma, Malignant)
08/2008 - 09/2005
2
Nasopharyngeal Carcinoma
07/2005 - 12/2002
2
Hodgkin Disease (Hodgkin's Disease)
07/2002 - 01/2002
1
Carcinoma (Carcinomatosis)
05/2014
1
Noninfiltrating Intraductal Carcinoma (DCIS)
05/2014
1
Hypoxia (Hypoxemia)
10/2012
1
Carcinogenesis
08/2012
1
Aplastic Anemia (Anemia, Hypoplastic)
02/2008
1
Necrosis
08/2006
1
Neoplasm Metastasis (Metastasis)
07/2005
1
Hypersensitivity (Allergy)
01/2005
1
Fanconi Anemia (Fanconi's Anemia)
01/2005
1
Genomic Instability
01/2005
1
Burkitt Lymphoma (Burkitt's Lymphoma)
03/2002
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2002
Drug/Important Bio-Agent (IBA)
5
Proteins (Proteins, Gene)
FDA Link
12/2012 - 03/2002
5
Caspases
IBA
07/2005 - 03/2002
4
Granzymes (Granzyme)
IBA
08/2008 - 01/2002
3
Caspase 9
IBA
01/2008 - 04/2005
3
Caspase 3 (Caspase-3)
IBA
07/2005 - 03/2002
2
Phenobarbital (Luminal)
FDA Link
05/2014 - 03/2012
2
ErbB Receptors (EGF Receptor)
IBA
12/2012 - 03/2012
2
Progesterone Receptors (Progesterone Receptor)
IBA
12/2012 - 03/2012
2
Biomarkers (Surrogate Marker)
IBA
12/2012 - 08/2012
2
Protease Inhibitors (Protease Inhibitor)
IBA
09/2005 - 01/2002
2
Antibodies
IBA
07/2005 - 03/2002
2
Caspase 8 (Caspase-8)
IBA
04/2005 - 04/2005
1
Bortezomib (Velcade)
FDA Link
09/2015
1
human AR protein
IBA
12/2012
1
Cyclin D1
IBA
12/2012
1
Keratins (Keratin)
IBA
12/2012
1
Carbonic Anhydrase IX
IBA
10/2012
1
TNF Receptor-Associated Factor 4
IBA
08/2012
1
Estrogen Receptors
IBA
03/2012
1
Apoptosis Regulatory Proteins
IBA
04/2010
1
Rituximab (Mabthera)
FDA Link
04/2010
1
Histocompatibility Antigens Class I
IBA
08/2008
1
Histocompatibility Antigens Class II
IBA
08/2008
1
thymoglobulin
FDA Link
02/2008
1
X-Linked Inhibitor of Apoptosis Protein
IBA
01/2008
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
11/2006
1
Aurora Kinase B
IBA
11/2006
1
Inhibitor of Apoptosis Proteins
IBA
09/2006
1
TNF-Related Apoptosis-Inducing Ligand
IBA
08/2006
1
Death Domain Receptors
IBA
08/2006
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
08/2006
1
Paraffin
IBA
09/2005
1
Antigens
IBA
07/2005
1
CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)
IBA
04/2005
1
Etoposide (VP 16)
FDA Link
Generic
04/2005
1
Fanconi Anemia Complementation Group D2 Protein
IBA
01/2005
1
Cisplatin (Platino)
FDA Link
Generic
01/2005
1
Platinum
IBA
01/2005
1
Effector Caspases
IBA
03/2002
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
03/2002
1
Serine Proteases (Serine Protease)
IBA
01/2002
1
Monoclonal Antibodies
IBA
01/2002
Therapy/Procedure
10
Drug Therapy (Chemotherapy)
04/2010 - 07/2002
8
Therapeutics
01/2014 - 03/2002
2
Ligation
08/2012 - 07/2012
1
Molecular Targeted Therapy
04/2010
1
Neoadjuvant Therapy
09/2006
1
Combination Drug Therapy (Combination Chemotherapy)
09/2006
1
Immunotherapy
09/2005
1
Radiotherapy
07/2005